Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacologic treatment of postprandial hypoglycemia after Roux-en-Y gastric bypass
2015-001086-50Phase 4Completed
- Sponsor
- Zealand University Hospital
- Start
- May 2015
- Modality
- Peptides, Small Molecules, Microbiome-Derived Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of acarbose, verapamil, sitagliptin, liraglutide, pasireotide LAR in postprandial hypoglycemia, sponsored by Zealand University Hospital. Started May 2015; status: completed.
02
Drugs
03
Conditions
postprandial hypoglycemia
Beyond the preview
Go deeper on 2015-001086-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001086-50.